Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Carey Thomas P

2. Date of Event Requiring Statement (MM/DD/YYYY) 2/6/2018

3. Issuer Name and Ticker or Trading Symbol

BROADRIDGE FINANCIAL SOLUTIONS, INC. [BR]

(Last) (First) (Middle)

5 DAKOTA DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Corporate VP /

(Street)

LAKE SUCCESS, NY 11042

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1726.0000 ⁽¹⁾	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
FY2015 RSUs	⁽²⁾	⁽²⁾	Common Stock	1376.0000	$0.0000	D
FY2016 RSUs	⁽³⁾	⁽³⁾	Common Stock	1097.0000	$0.0000	D
FY2017 RSUs	⁽⁴⁾	⁽⁴⁾	Common Stock	1051.0000	$0.0000	D
Stock Option (Right to Buy)	2/10/2015	2/10/2024	Common Stock	1246.0000 ⁽⁵⁾	$36.9700	D
Stock Option (Right to Buy)	2/10/2018	2/10/2024	Common Stock	25879.0000 ⁽⁶⁾	$36.9700	D
Stock Option (Right to Buy)	2/9/2016	2/9/2025	Common Stock	7222.0000 ⁽⁷⁾	$50.9500	D
Stock Option (Right to Buy)	2/8/2017	2/8/2026	Common Stock	5696.0000 ⁽⁸⁾	$51.9500	D
Stock Option (Right to Buy)	2/10/2018	2/10/2027	Common Stock	5399.0000 ⁽⁹⁾	$67.3200	D

Explanation of Responses:
(1)	Amount includes 1,651 Restricted Stock Units ("RSUs") granted under Broadridge's 2007 Omnibus Award Plan as determined at the end of a two year performance period and represents a like number of shares of Broadridge common stock. The RSUs will vest and convert into shares of common stock on April 6, 2018.
(2)	Restricted Stock Units granted under Broadridge's 2007 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The RSUs will vest and convert into shares of common stock on April 6, 2018.
(3)	Restricted Stock Units granted under Broadridge's 2007 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The RSUs will vest and convert into shares of common stock on April 6, 2019.
(4)	Restricted Stock Units granted under Broadridge's 2007 Omnibus Award Plan representing a like number of shares of Broadridge common stock. The RSUs will vest and convert into shares of common stock on April 6, 2020.
(5)	Stock Option granted under Broadridge's Omnibus Award Plan on February 10, 2014, vesting equally over 4 years beginning February 10, 2015, of which 1,246 shares are currently exercisable.
(6)	Special Stock Option granted under Broadridge's 2007 Omnibus Award Plan on February 10, 2014, of which 25,879 shares are currently exercisable.
(7)	Stock Option granted under Broadridge's Omnibus Award Plan on February 9, 2015, vesting equally over 4 years beginning February 9, 2016, of which 5,416 shares are currently exercisable.
(8)	Stock Option granted under Broadridge's Omnibus Award Plan on February 8, 2016, vesting equally over 4 years beginning February 8, 2017, of which 2,848 shares are currently exercisable.
(9)	Stock Option granted under Broadridge's Omnibus Award Plan on February 10, 2017, vesting equally over 4 years beginning February 10, 2018, of which 1,349 shares are currently exercisable.

Remarks:
poacarey.txt

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Carey Thomas P 5 DAKOTA DRIVE LAKE SUCCESS, NY 11042			Corporate VP

Signatures
/s/ Thomas P Carey		2/14/2018
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.